Virax Biolabs VRAX
NASDAQ VRAX
$1.37 -0.03 (-2.14%)
At close: Oct 20, 2026 · 4:00 PM EDT

Virax Biolabs (VRAX) Receivables - Other (2021)

Updated

Virax Biolabs (VRAX) reported Receivables - Other of -$54,497 for fiscal Q4 2021 (quarter ended Mar 31, 2021).

Analysis

Virax Biolabs (VRAX) Receivables - Other (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 254.87 Bn 233.89 Bn 4.88 Bn
2 Abbott Laboratories 178.85 Bn 149.28 Bn 7.27 Bn
3 Danaher 158.49 Bn 142.30 Bn 3.61 Bn
4 Intuitive Surgical 154.99 Bn 134.41 Bn 1.96 Bn
5 Medtronic 121.02 Bn 86.28 Bn 6.34 Bn
6 Stryker 116.94 Bn 103.05 Bn 4.50 Bn
7 Boston Scientific 66.98 Bn 61.75 Bn 3.85 Bn
8 Becton Dickinson 53.23 Bn 50.38 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 Virax Biolabs 536,746.51 -20.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -54,497.00
API Access

Virax Biolabs Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=VRAX&period=max&api_key=YOUR_API_KEY